InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the full record of transactions filed by Reed Joshua, Chief Financial Officer. Insider active across 2 companies, notably Aldeyra Therapeutics, Inc.. In total, 6 disclosures have been published. Split: 0 buy · 3 sells. Total volume traded: €272k. History available since 30 March 2022. The latest transaction was filed on 1 July 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
6 of 6 declarations
Joshua Reed is the Chief Financial Officer of Aldeyra Therapeutics, Inc. He is responsible for the company's financial management, including budgeting and financial reporting. His expertise is essential for ensuring the financial health of the organization.